NCT00272584View on ClinicalTrials.gov

CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia

PHASE4CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

January 31, 2004

Conditions
Psychosis, Schizophrenia
Interventions
DRUG

Risperidone

Trial Locations (1)

Unknown

UBC Hospital, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT00272584 - CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia | Biotech Hunter | Biotech Hunter